Table 4.
Quality of counseling in patients prescribed an ACT as assessed during exit interviews in health facility surveys in Maputo, Zambezia, and Cabo Delgado Provinces, Mozambique, 2018
Maputo | Zambezia | Cabo Delgado | ||||
---|---|---|---|---|---|---|
95% CI | 0 | 95% CI | 90 | 95% CI | ||
Given first dose at health facility | 7 | 2–21 | 8 | 4–16 | 7 | 3–14 |
Given instructions on how to take ACT | 100 | 100–100 | 92 | 87–96 | 79 | 68–87 |
Able to correctly recite dosing schedulea | 62 | 28–87 | 58 | 45–70 | 58 | 38–76 |
Received instructions to: | ||||||
Take AL with food or milk | 18 | 3–57 | 11 | 6–19 | 40 | 22–61 |
Take AL on empty stomach | 9 | 1–43 | 0 | 0.09–2.30 | 0 | 0.02–0.84 |
Complete all doses | 72 | 34–93 | 42 | 31–55 | 38 | 20–60 |
Return if worse | 66 | 30–90 | 38 | 29–48 | 40 | 22–61 |
Return if no improvement | 18 | 5–49 | 39 | 29–50 | 38 | 21–60 |
ACT, artemisinin-based combination therapy; AL, artemether–lumefantrine; CI, confidence interval
aCorrect number of tablets per dose, doses per day, and total duration of treatment. Calculated only for subset of patients prescribed the correct dose